Cleveland Clinic Taussig Cancer Institute
Avatar

Targeted Therapy of Melanoma: Where Are We Going?

By Cleveland Clinic Taussig Cancer Institute FEATURING Pauline Funchain
By Cleveland Clinic Taussig Cancer Institute FEATURING Pauline Funchain
223 views
December 11, 2018
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
13:47
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Expanding the Benefit - Dabrafenib/Tramet…

Feat. V. Subbiah
23:09
Total Health

Key Updates in Skin Melanoma

Feat. R. Seedor
06:39
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Final Analysis of Distant Metastasis-Free…

Feat. J. Luke
17:39
Melanoma Bridge 2023

Major Emerging Paradigm Shifts That Will Change Melanoma Management …

Feat. A. Eggermont
24:14
Masterclasses in Dermatology

Advances in the Treatment of Melanoma

Feat. D. Fisher
05:20
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Impact of Immune Checkpoint Inhibition on…

Feat. E. Buchbinder
08:38
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase 3 Trial Comparing Fianlimab + Cem…

Feat. T. Panella
19:52
OncoAlert

Melanoma Updates: Adjuvant Therapy, Advanced Disease, Uveal Melanoma…

Feat. A. Betof Warner
21:04
Penn Medicine Abramson Cancer Center

Pediatric Melanoma

Feat. M. Jen
05:37
Melanoma Bridge 2023

COLUMBUS 7-Year Update: Encorafenib + Binimetinib vs. Vemurafenib or…

Feat. R. Dummer
08:46
Sapna Patel

Neoadjuvant Immunotherapy in the Treatment of Melanoma: What Do We K…

13:12
2023 Year in Review

Year in Review: Surgical Treatment of Acral Melanoma

Feat. M. Leventer
14:00
Melanoma Bridge 2023

Is SLN Biopsy No Longer Necessary for Patients With High-Risk Primar…

Feat. J. Luke
08:27
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Significant Durable Response With Fianlim…

Feat. O. Hamid
04:45
Sapna Patel

Optimal Duration of Neoadjuvant Treatment in Melanoma: What We Do No…

17:38
Melanoma 2024: 34th Annual Cutaneous Malignancy Update

Beyond the Primary: Comprehensive Evaluation of the Melanoma Patient…

Feat. F. Fish
25:10
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

Immunotherapy Combinations in Melanoma in 2024

Feat. J. Moyers
02:49
GRACE

Major Advances in Uveal Melanoma

Feat. M. Postow
20:32
Melanoma Bridge 2023

Targeted Therapy in BRAF-Mutated Metastatic Melanoma

Feat. R. Dummer
14:36
Melanoma Bridge 2023

Treating PD-1 Refractory Melanoma With TIL Therapy vs. Nivo+Ipi: Pro…

Feat. J. Smithy